Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Hemoglobin A1C (HbA1C) Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Hemoglobin A1C (HbA1C) Testing estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$2.3 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2022-2030.
Ion-Exchange High Performance Liquid Chromatography (HPLC), one of the segments analyzed in the report, is projected to record a 7.6% CAGR and reach US$915.7 Million by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Immunoassays segment is readjusted to a revised 8.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $397.5 Million, While China is Forecast to Grow at 9.5% CAGR
The Hemoglobin A1C (HbA1C) Testing market in the U.S. is estimated at US$397.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$274.2 Million by the year 2030 trailing a CAGR of 9.5% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 6.8% respectively over the 2022-2030 period.
Within Europe, Germany is forecast to grow at approximately 5.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$239.1 Million by the year 2030.
Select Competitors (Total 110 Featured) -
- A.Menarini Diagnostics Ltd.
- Abbott Laboratories
- ARKRAY, Inc.
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- Diazyme Laboratories, Inc.
- EKF Diagnostics Holdings Plc
- HemoCue AB
- OSANG Healthcare Co., Ltd
- PTS Diagnostics
- Roche Diagnostics
- Siemens Healthineers
- Trinity Biotech plc
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 511 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $1.4 Billion |
| Forecasted Market Value (USD) by 2030 | $2.3 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Impact of Covid-19 and a Looming Global Recession
- Year 2021 in Review and Near-term Outlook
- Prolonged Pandemic, Ukraine-Russia Conflict and Ensuing Economic Disruptions Impact Growth Outlook
- World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2021, 2022 and 2023
- Impact of COVID-19 on Hemoglobin A1C Testing
- COVID-19 Pandemic Creates New Challenge of HbA1c Laboratory Test Underutilization
- Competition
- Hemoglobin A1C (HbA1C) Testing - Global Key Competitors Percentage Market Share in 2022 (E)
- HbA1c Devices: Critical Role in Monitoring & Management of Diabetes
- Role of HbA1c Testing in Diabetes Diagnosis and Management
- Interpretation of HbA1c in NGSP and IFCC Units as per the American Diabetes Association
- Global Market Analysis and Prospects
- World Hemoglobin A1C (HBA1C) Testing Market Set to Witness Rapid Growth
- While Developed Regions Lead, Asia-Pacific to Spearhead Long-term Growth
- Chromatography-based Hb Testing Devices Lead Market
- Ion-Exchange HPLC Test for Hemoglobin A1c Makes Notable Headway as Reliable Diabetes Screening Tool
- HPLC Testing for HbA1c Retains Value as Gold Standard
- Ion-exchange HPLC Testing: Primary Merits for Different Stakeholders
- HbA1c Testing to Witness Skyrocketing Interest with Focus on POC Testing for Diabetes
- Diabetes Screening to Receive Special Thrust from Rapid Point-Of-Care HbA1c Testing
- Recent Market Activity
- WORLD BRANDS
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Increasing Diabetes Prevalence and the Need for Diabetes Management to Prop-up Demand for HbA1c Monitoring Devices
- World Diabetes and Population Statistics (2019, 2030 & 2045)
- Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
- World Diabetes Prevalence (2000-2045P)
- Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
- Diabetes Emerges as One of the Leading Causes of Mortality
- Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region: 2019
- Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
- Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
- Point-of-Care (POC) HbA1c Testing Products/Analyzers of Select Players
- Laboratory-based HbA1c Testing Products/Analyzers of Select Players
- Major Testing Methods in POC HbA1c Tests
- High Risk of Diabetes in Aging Demographics Promises Growth in HbA1c Testing Devices Market
- Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
- Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
- Increasing Obesity Levels Underpins Market Growth
- Average Per Capita Annual Health Expenditure (In US$) due to Obesity
- Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
- Increasing Healthcare Expenditure Fuels Demand for HbA1c Testing Devices
- World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
- Variants & Derivatives Affecting Accuracy of HbA1c Testing
- Rising Menace of Undiagnosed Diabetes Turns Heads towards Hemoglobin A1c Testing
- Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
- Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
- Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
- Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Hemoglobin A1C Testing
- Technology Developments Transform Diagnostics in Diabetes Care
- Non-Invasive Glucose Meters and Continuous Glucose Monitors Offer Viable Alternative to Hemoglobin A1c Monitoring
- Role of Hemoglobin A1C Monitoring in Patients with Chronic Kidney Disease
- HbA1C Testing Holds Significance as Screening Strategy for Gestational Diabetes
- Home HbA1C Testing Market
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/sqla3r
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
